
PulseSight Therapeutics Publishes Data Supporting Transferrin Therapy for Dry AMD and Geographic Atrophy
PulseSight Therapeutics has announced the publication of new peer-reviewed research that reinforces the therapeutic promise of transferrin (Tf) in treating dry age-related macular degeneration (AMD) and its advanced stage, geographic atrophy (GA). The …